David Turkaly
Stock Analyst at Citizens JMP
(0.27)
# 4,501
Out of 4,983 analysts
440
Total ratings
39.5%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENOV Enovis | Reiterated: Buy | $55 → $47 | $17.80 | +164.04% | 5 | Sep 2, 2026 | |
| SYK Stryker | Reiterated: Buy | $440 → $400 | $280.13 | +42.79% | 22 | Aug 3, 2026 | |
| AXGN Axogen | Reiterated: Buy | $50 → $55 | $45.29 | +21.45% | 31 | Jul 30, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $85 → $115 | $100.80 | +14.09% | 21 | May 8, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $7 → $6 | $4.69 | +27.93% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Buy | $125 → $105 | $94.25 | +11.41% | 29 | Apr 29, 2026 | |
| TELA TELA Bio | Reiterated: Buy | $5 → $3 | $1.29 | +132.56% | 23 | Mar 27, 2026 | |
| APYX Apyx Medical | Upgraded: Buy | $8 | $3.03 | +164.03% | 34 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Reiterated: Buy | $35 → $25 | $21.78 | +14.78% | 37 | Oct 10, 2025 | |
| GMED Globus Medical | Reiterated: Hold | n/a | $74.16 | n/a | 24 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $15.10 | n/a | 31 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.97 | n/a | 23 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $107.60 | n/a | 33 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $280 | $208.04 | n/a | 40 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $18.04 | n/a | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $125.59 | n/a | 24 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.64 | n/a | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.38 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.01 | n/a | 2 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $69.23 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $8.94 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.49 | n/a | 1 | Jun 25, 2009 |
Enovis
Sep 2, 2026
Reiterated: Buy
Price Target: $55 → $47
Current: $17.80
Upside: +164.04%
Stryker
Aug 3, 2026
Reiterated: Buy
Price Target: $440 → $400
Current: $280.13
Upside: +42.79%
Axogen
Jul 30, 2026
Reiterated: Buy
Price Target: $50 → $55
Current: $45.29
Upside: +21.45%
Lantheus Holdings
May 8, 2026
Reiterated: Buy
Price Target: $85 → $115
Current: $100.80
Upside: +14.09%
MiMedx Group
Apr 30, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $4.69
Upside: +27.93%
Zimmer Biomet Holdings
Apr 29, 2026
Reiterated: Buy
Price Target: $125 → $105
Current: $94.25
Upside: +11.41%
TELA Bio
Mar 27, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $1.29
Upside: +132.56%
Apyx Medical
Nov 12, 2025
Upgraded: Buy
Price Target: $8
Current: $3.03
Upside: +164.03%
OrthoPediatrics
Oct 10, 2025
Reiterated: Buy
Price Target: $35 → $25
Current: $21.78
Upside: +14.78%
Globus Medical
Aug 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $74.16
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $25
Current: $15.10
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: $7
Current: $2.97
Upside: n/a
May 20, 2025
Reiterated: Buy
Price Target: $100
Current: $107.60
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $265 → $280
Current: $208.04
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $32
Current: $18.04
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $125.59
Upside: n/a
Mar 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.64
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $11.38
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $9.01
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $69.23
Upside: n/a
Jun 3, 2016
Reiterated: Buy
Price Target: $17
Current: $8.94
Upside: n/a
Jun 25, 2009
Downgraded: Hold
Price Target: n/a
Current: $3.49
Upside: n/a